Presentation, etiology, diagnosis, and management of camptocormia

European Neurology
Josef Finsterer, Walter Strobl

Abstract

Camptocormia (bent spine syndrome, cyphose hystérique) is an abnormality characterized by severe forward flexion of the thoracolumbar spine which typically increases during walking or standing and completely disappears in supine position. Camptocormia can be due to central nervous system diseases, such as Parkinson's disease, dystonia, multisystem atrophy, or Alzheimer's disease, due to peripheral nervous system diseases, such as primary myopathy, secondary myopathy, motor neuron disease, myasthenia, or chronic inflammatory demyelinating polyneuropathy, due to side effects of drug treatment, due to disc herniation, arthritis or spinal trauma, or due to paraneoplasia. Only rarely may camptocormia be attributable to psychiatric disease. The diagnosis is based on clinical findings, imaging of the cerebrum or spine, needle electromyography, or muscle biopsy. Treatment options are limited and frequently futile and rely on conservative measures, such as psychotherapy, physiotherapy, use of orthoses, drugs, injection of botulinum toxin, withdrawal of causative drugs, electroconvulsive therapy, or invasive measures, such as surgical correction or deep brain stimulation. The outcome is generally fair. Some patients profit from therapy w...Continue Reading

Citations

Dec 14, 2011·Acta Neuropathologica·Arne WredeWalter J Schulz-Schaeffer
May 29, 2012·Current Neurology and Neuroscience Reports·Gonzalo J Revuelta
Oct 12, 2012·CNS Drugs·Munazza Sophie, Blair Ford
Nov 23, 2013·Journal of Clinical Neuromuscular Disease·Ana Castrillo SanzJ Duarte García-Luis
Mar 15, 2013·Neuropsychiatric Disease and Treatment·David J Pedrosa, Lars Timmermann
Jun 1, 2014·Skeletal Radiology·Mickaël OhanaRobert-Yves Carlier
Mar 19, 2014·Acta neurologica Belgica·Patrick GillardinChristiaan Van der Linden
Oct 24, 2015·Neuromuscular Disorders : NMD·Matteo GaribaldiGiovanni Antonini
Apr 23, 2015·Muscle & Nerve·Partha S Ghosh, Margherita Milone
Sep 28, 2015·Journal of Neural Transmission·Ruxandra Julia VorovenciAngelo Antonini
Nov 22, 2012·Muscle & Nerve·Andrew R FindlayKevin M Flanigan
Sep 29, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Morinobu SekiUNKNOWN Keio Parkinson's Disease Database
Feb 14, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Walter J Schulz-SchaefferChristian Oehlwein
Jun 17, 2015·Toxicon : Official Journal of the International Society on Toxinology·Kelly L BertramCarlo Colosimo
May 2, 2015·Journal of Neurology·N G MargrafG Deuschl
Dec 26, 2012·Clinical Neurology and Neurosurgery·Perrine DevicPhilippe Petiot
Jul 2, 2014·Parkinsonism & Related Disorders·Subhashie Wijemanne, Joohi Jimenez-Shahed
Nov 26, 2013·Parkinsonism & Related Disorders·René ReeseJens Volkmann
Dec 4, 2014·Journal of Child and Adolescent Psychopharmacology·Arnab BhattacharyaVinod Kumar Sinha
Mar 13, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J-B ChansonA Echaniz-Laguna
Nov 5, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Toko SatoYoshihisa Takiyama
Nov 20, 2016·Muscle & Nerve·Nicolas TaisneThierry Cardon
May 2, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Yoshiharu AriiTakao Mitsui
Sep 27, 2016·The Journal of ECT·Huseyin BayazitHasan Kandemir
Apr 7, 2018·Current Neurology and Neuroscience Reports·Bettina DebûElena Moro
Mar 11, 2011·Neuro-degenerative Diseases·Matthias PonfickJan Kassubek
Oct 13, 2018·Neurological Research·Maria Angela Samis ZellaDirk Woitalla
Jun 15, 2015·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Clemens SeidelKathrin Hering
Jan 27, 2017·Journal of Movement Disorders·Ju-Hee OhJoong-Seok Kim
Apr 21, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Wooyoung JangHee-Tae Kim
Feb 13, 2016·Journal of Clinical Psychopharmacology·Emilio González-PablosSilvia Cámara Barrio
Feb 2, 2015·Movement Disorders Clinical Practice·Santiago Perez-LloretWassilios G Meissner
Nov 22, 2019·BMC Musculoskeletal Disorders·Matthias TürkRolf Schröder
Jun 3, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Enrica FilippelliAldo Quattrone
May 17, 2017·NeuroRehabilitation·Siria Di MartinoCarmelo Chisari
Dec 21, 2018·Journal of Physical Therapy Science·Yuki KawamiToshihiro Akisue
May 16, 2017·Journal of Neurology·Matteo GaribaldiElena Maria Pennisi
Jun 20, 2021·Rheumatology·Valérie LeclairUNKNOWN Canadian Inflammatory Myopathy Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
Hiroshi KataokaSatoshi Ueno
Movement Disorders : Official Journal of the Movement Disorder Society
Nils MargrafG Deuschl
Clinical Neurology and Neurosurgery
Perrine DevicPhilippe Petiot
© 2021 Meta ULC. All rights reserved